Genitourinary Cancers

Is an Injectable Antiresportive More Popular?

Increased levels of physical activity after a diagnosis of prostate cancer are associated with significantly better survival, according to the results of a new, large prospective cohort study. Read More ›

How an Injectable Became a Significant Tool In Bone Health
Pam Skurkay talks about when she and other nurses began using a medicine to treat bone-related health issues and how they eventually allowed outside medical offices the pre-authorization to use it. Read More ›

Decreasing Skeletal Issues
Dianna Shafer and Angela Hunter talk about the DEXA scan results, and how the implementation of a specific therapy helped decrease bone-related issues. Read More ›

Bone Health and Prostate Cancer
Dianna Shafer talks about how bone health goes with prostate health treatment, and trying to avoid skeletal health events. Read More ›

Immunotherapy and DEXA Scans
Pam Skurkay, Dianna Shafer, and Angela Hunter discuss the positive scan results they are seeing post-immunotherapy when using denosumab. Read More ›

Both abiraterone and enzalutamide are approved by the US Food and Drug Administration for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Both drugs have different mechanisms of action and different adverse event profiles, but there are limited data comparing them directly. Read More ›

Regular use of aspirin appeared to reduce the risk for dying from lethal prostate cancer in a large observational study reported at the 2016 Genitourinary Cancers Symposium. Read More ›

Docetaxel added to androgen-deprivation therapy (ADT) improves survival for men with metastatic hormone-sensitive prostate cancer (mHSPC), as shown by the pivotal ECOG 3805 CHAARTED trial. Read More ›

Men with low-risk prostate cancer are typically offered management with active surveillance, which entails regular office visits, digital rectal exam, MRI scans, prostate-specific antigen (PSA) testing, and prostate biopsy at physician-specified intervals. Read More ›

Page 2 of 6

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: